Abdominal infection

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
4 Unique IMPs
1 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 1
P Parasitology (ATC P) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Azole antifungal 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Pfizer Inc. Commercial
    AVIBACTAM SODIUM; AZTREONAM; AZTREONAM, AVIBACTAM SODIUM; METRONIDAZOLE
    2022-501575-12-00 4 countries 2023 n=20
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pfizer Inc. Commercial 1 Phase II 1
New trials by year
2023
1
← All indication landscapes